Clinical Trial Update: Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for ABX-002 as an adjunctive treatment for depressive episodes in adults with bipolar disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• ABX-002

Snippet

Sponsor: Autobahn Therapeutics, Inc. | Conditions: Bipolar Disorder Depression | Phase 2 | Status: RECRUITING